Related Articles
Investigation of factors associated with reduced clinical benefits of personalized peptide vaccination for pancreatic cancer
Personalized peptide vaccination for advanced biliary tract cancer: IL-6, nutritional status and pre-existing antigen-specific immunity as possible biomarkers for patient prognosis
A randomized phase III trial of personalized peptide vaccination for castration‑resistant prostate cancer progressing after docetaxel
Identification of biomarkers for personalized peptide vaccination in 2,588 cancer patients
Feasibility study of personalized peptide vaccination for advanced non-small cell lung cancer patients who failed two or more treatment regimens